Abstract
Magnetic hyperthermia therapy (MHT) has emerged as a promising non- invasive approach for tumor treatment. 磁気温熱療法(MHT)は、腫瘍治療における有望な非侵襲的治療法として注目されている。
This work presents a novel paradigm for the biomimetic synthesis of high-performance magnetoferritins and pave the way for their clinical application in MHT.
本研究は、高性能なマグネトフェリチンの生体模倣的合成に向けた新たなパラダイムを提示し、MHTにおけるその臨床応用への道を開くものである。
Introduction
語句の説明
MHT:Magnetic hyperthermia therapy
MNPs:magnetic nanoparticles
AMF:alternating magnetic field
safety limit
PNCs:magnetic protein nanocages
FOCs:ferroxidase centers
Dps:DNA-binding proteins
ferritins
virus capsid-like encapsulins
unique advantages: (1) The protein shell provides natural hydrophilicity and ensures excellent colloidal stability; (2) Their inherent biocompatibility minimizes inflammatory and immuno-logical responses [10]; (3) The protein architecture precisely controls the morphology, size, and crystallinity of the encapsulated magnetic core.
ferritin stands out as a ubiquitous iron-storage protein that plays a crucial role in cellular iron homeostasis
magnetoferritin:Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science,
Owing to its exceptional biocompatibility, monodispersity, and chemical modifiability, magnetoferritin has found widespread applications in targeted drug delivery and magnetic resonance imaging (MRI) contrast agents
SAR: specific absorption rate
dual-strategy approach
Materials and methods
Materials
Ammonium ferrous sulfate:
cobalt(II) sulfate:
Sodium chloride:NaCl
Tris
sodium hydroxide (NaOH)
methods
anaerobic chamber
dosing system (TIAMO software)
The total metal ion concentration was maintained at 50 mmol·L−1 for all syntheses